Other receivables and other payables (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
| Trade and other payables [abstract] |
|
| Schedule of other receivables |
| | | | | Figures in million – SA rand | | | | | Rates and taxes receivable | | | | | | | | | | Section 45X credit receivable | | | | | | | | | | | | | | | Reconciliation of the non-current and current portion of the other receivables: | | | | | | | | | | Current portion of other receivables | | | | | Non-current portion of other receivables | | | | |
|
| Schedule of other payables |
| | | | Figures in million – SA rand | | | | Contingent consideration (Kroondal acquisition) | | | | Deferred/contingent consideration (Pandora acquisition) | | | | Marikana dividend obligation | | | | Keliber dividend obligation | | | | Metals borrowings liability | | | | | | | | Gold and zinc hedge derivative liability | | | | | | | | | | | | Reconciliation of the non-current and current portion of the other receivables: | | | | | | | | Current portion of other payables | | | | Non-current portion of other payables | | | |
1The revised 2024 balance includes the additional payment in respect of the Reldan business combination amounting to R96 million (see note 16.2)
|
| Schedule of deferred payment/consideration |
The Kroondal contingent consideration movement for the year is as follows: | | | | | Figures in million – SA rand | | | | | Balance at the beginning of the year | | | | | Contingent consideration on acquisition of subsidiary | | | | | | | | | | (Gain)/loss on revised estimated cash flows | | | | | Balance at end of the year | | | | |
The Pandora deferred consideration movement for the year is as follows: | | | | | Figures in million – SA rand | | | | | Balance at the beginning of the year | | | | | | | | | | Loss on revised estimated cash flows | | | | | | | | | | Balance at end of the year | | | | |
|
| Schedule of movement in dividend obligation |
The following table summarises the changes in the Marikana dividend obligation: | | | | | Figures in million – SA rand | | | | | Balance at the beginning of the year | | | | | Interest — unwinding of amortised cost | | | | | Gain on revised estimated cash flows | | | | | | | | | | Balance at end of the year | | | | |
The following table summarises the changes in the Keliber dividend obligation: | | | | | Figures in million – SA rand | | | | | Balance at the beginning of the year | | | | | Initial recognition of the Keliber dividend obligation | | | | | (Gain)/loss on revised estimated cash flows1 | | | | | Interest — unwinding of amortised cost | | | | | Foreign currency translation reserve | | | | | Balance at end of the year | | | | |
1The gain on revised estimated cash flow for the year ended 31 December 2025 is primarily as a result of a decrease in the long term lithium hydroxide price, which resulted in decreased expected future cash flows from Keliber
|
| Disclosure of information and assumptions used for measuring obligations |
At 31 December 2025 the following assumptions were applied in measuring the Keliber dividend obligation: | | | | | | | | | | Average lithium hydroxide price | | | | | | | | | | | | | | | | | | | |
|
| Schedule of metals borrowings liability |
The following table summarises the changes in the metals borrowings liability: | | | | | Figures in million – SA rand | | | | | Balance at the beginning of the year | | | | | Initial recognition on acquisition of subsidiary | | | | | | | | | | Non-cash advances received | | | | | | | | | | Settlements through delivery of metals (non-cash) | | | | | Loss/(gain) on commodity price movements | | | | | Foreign currency translation reserve | | | | | Balance at end of the year | | | | |
|
| Schedule of deferred/contingent payments made |
The table below summarises the cash deferred/contingent payments made during the year on the obligations set out above: | | | | | Figures in million – SA rand | | | | | Deferred payment (Rustenburg operation) | | | | | Deferred/contingent consideration (Pandora acquisition) | | | | | Contingent consideration (Kroondal acquisition) | | | | | | | | | | Payments in excess of the original fair value (operating cash flows) | | | | | Payments up to initial fair value (investing cash flows) | | | | |
|